Diagnostic and Therapeutic Applications of Microarrays in Liver Transplantation

Recruiting now

Conditions studied: Liver Dysfunction

In brief

INTERLIVER is a prospective observational study of the relationship of the molecular phenotype of 300 liver transplant biopsies to the histologic phenotype and the clinical features and outcomes. A segment of a biopsy performed as standard-of-care for indications, or by center protocol, will be used for gene expression study.

Key facts

Study ID
NCT03193151
Run by
University of Alberta
People needed
300
Starts
2017-12-19
Expected to finish
2028-12-01
Last updated by the study team
2026-06-04

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.